CARISMA Therapeutics (NASDAQ:CARM) just reported results for the fourth quarter of 2023. CARISMA Therapeutics reported earnings per share of -52 cents. This was above the analyst estimate for EPS of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results